Clinical experience with stem cells and other cell therapies in neurological diseases

Journal of the Neurological Sciences

Volumn 324, Issue 1-2, 2013, Pages 1-9

  Karussis, Dimitrios ^a   Petrou, Panayiota ^a   Kassis, Ibrahim ^a  

^a HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

Author keywords

Clinical trials; Mesenchymal stem cells; Neurological diseases; Stem cells

Indexed keywords

CYCLOSPORIN; IMMUNOSUPPRESSIVE AGENT;

AMYOTROPHIC LATERAL SCLEROSIS; CELL RENEWAL; CELL SURVIVAL; CELL THERAPY; CEREBROVASCULAR DISEASE; EMBRYO CELL; EXPERIENCE; HUMAN; HUNTINGTON CHOREA; MEDICAL LITERATURE; MOTOR DYSFUNCTION; MULTIPLE SCLEROSIS; MUSCLE DISEASE; NERVE CELL LESION; NEUROLOGIC DISEASE; NONHUMAN; PARKINSON DISEASE; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; REGENERATION; REVIEW; SEIZURE; SHY DRAGER SYNDROME; SOMATIC CELL; STEM CELL TRANSPLANTATION; SUBDURAL HEMATOMA;

ANIMALS; CLINICAL TRIALS AS TOPIC; HUMANS; MESENCHYMAL STEM CELL TRANSPLANTATION; NERVOUS SYSTEM DISEASES; PILOT PROJECTS; STEM CELL TRANSPLANTATION; TISSUE THERAPY;

EID: 84870892437     PISSN: 0022510X     EISSN: 18785883     Source Type: Journal    
DOI: 10.1016/j.jns.2012.09.031     Document Type: Review

References (121)

1. C. Buhnemann, A. Scholz, C. Bernreuther, C.Y. Malik, H. Braun, and M. Schachner Neuronal differentiation of transplanted embryonic stem cell-derived precursors in stroke lesions of adult rats Brain 129 2006 3238 3248
2. Y. Fan, F. Shen, T. Frenzel, W. Zhu, J. Ye, and J. Liu Endothelial progenitor cell transplantation improves long-term stroke outcome in mice Ann Neurol 67 2010 488 497
3. I. Kassis, N. Grigoriadis, B. Gowda-Kurkalli, R. Mizrachi-Kol, T. Ben-Hur, and S. Slavin Neuroprotection and immunomodulation with mesenchymal stem cells in chronic experimental autoimmune encephalomyelitis Arch Neurol 65 2008 753 761
4. Y. Li, J. Chen, X.G. Chen, L. Wang, S.C. Gautam, and Y.X. Xu Human marrow stromal cell therapy for stroke in rat: neurotrophins and functional recovery Neurology 59 2002 514 523
5. E. Zappia, S. Casazza, E. Pedemonte, F. Benvenuto, I. Bonanni, and E. Gerdoni Mesenchymal stem cells ameliorate experimental autoimmune encephalomyelitis inducing T-cell anergy Blood 106 2005 1755 1761
6. J. Zhang, Y. Li, J. Chen, Y. Cui, M. Lu, and S.B. Elias Human bone marrow stromal cell treatment improves neurological functional recovery in EAE mice Exp Neurol 195 2005 16 26
7. M. Blurton-Jones, M. Kitazawa, H. Martinez-Coria, N.A. Castello, F.J. Muller, and J.F. Loring Neural stem cells improve cognition via BDNF in a transgenic model of Alzheimer disease Proc Natl Acad Sci U S A 106 2009 13594 13599
8. S. Corti, F. Locatelli, C. Donadoni, M. Guglieri, D. Papadimitriou, and S. Strazzer Wild-type bone marrow cells ameliorate the phenotype of SOD1-G93A ALS mice and contribute to CNS, heart and skeletal muscle tissues Brain 127 2004 2518 2532
9. O. Einstein, N. Fainstein, I. Vaknin, R. Mizrachi-Kol, E. Reihartz, and N. Grigoriadis Neural precursors attenuate autoimmune encephalomyelitis by peripheral immunosuppression Ann Neurol 61 2007 209 218
10. D.M. Karussis, S. Slavin, A. Ben-Nun, H. Ovadia, U. Vourka-Karussis, and D. Lehmann Chronic-relapsing experimental autoimmune encephalomyelitis (CR-EAE): treatment and induction of tolerance, with high dose cyclophosphamide followed by syngeneic bone marrow transplantation J Neuroimmunol 39 1992 201 210
11. H.J. Lee, K.S. Kim, I.H. Park, and S.U. Kim Human neural stem cells over-expressing VEGF provide neuroprotection, angiogenesis and functional recovery in mouse stroke model PLoS One 2 2007 e156
12. N. Nakao, M. Ogura, K. Nakai, and T. Itakura Embryonic striatal grafts restore neuronal activity of the globus pallidus in a rodent model of Huntington's disease Neuroscience 88 1999 469 477
13. H.J. Park, G. Bang, B.R. Lee, H.O. Kim, and P.H. Lee Neuroprotective effect of human mesenchymal stem cells in an animal model of double toxin-induced multiple system atrophy parkinsonism Cell Transplant 20 2011 827 835
14. H.J. Park, P.H. Lee, O.Y. Bang, G. Lee, and Y.H. Ahn Mesenchymal stem cells therapy exerts neuroprotection in a progressive animal model of Parkinson's disease J Neurochem 107 2008 141 151
15. S. Pluchino, A. Quattrini, E. Brambilla, A. Gritti, G. Salani, and G. Dina Injection of adult neurospheres induces recovery in a chronic model of multiple sclerosis Nature 422 2003 688 694
16. S. Stemberger, A. Jamnig, N. Stefanova, G. Lepperdinger, M. Reindl, and G.K. Wenning Mesenchymal stem cells in a transgenic mouse model of multiple system atrophy: immunomodulation and neuroprotection PLoS One 6 2011 e19808
17. A. Taguchi, T. Soma, H. Tanaka, T. Kanda, H. Nishimura, and H. Yoshikawa Administration of CD34 + cells after stroke enhances neurogenesis via angiogenesis in a mouse model J Clin Invest 114 2004 330 338
18. A.G. Xuan, D.H. Long, H.G. Gu, D.D. Yang, L.P. Hong, and S.L. Leng BDNF improves the effects of neural stem cells on the rat model of Alzheimer's disease with unilateral lesion of fimbria-fornix Neurosci Lett 440 2008 331 335
19. J.A. Thomson, J. Itskovitz-Eldor, S.S. Shapiro, M.A. Waknitz, J.J. Swiergiel, and V.S. Marshall Embryonic stem cell lines derived from human blastocysts Science 282 1998 1145 1147
20. M. Kim, A. Habiba, J.M. Doherty, J.C. Mills, R.W. Mercer, and J.E. Huettner Regulation of mouse embryonic stem cell neural differentiation by retinoic acid Dev Biol 328 2009 456 471
21. U. Ben-David, and N. Benvenisty The tumorigenicity of human embryonic and induced pluripotent stem cells Nat Rev Cancer 11 2011 268 277
22. F.H. Gage Mammalian neural stem cells Science 287 2000 1433 1438
23. Y. Jiang, B.N. Jahagirdar, R.L. Reinhardt, R.E. Schwartz, C.D. Keene, and X.R. Ortiz-Gonzalez Pluripotency of mesenchymal stem cells derived from adult marrow Nature 418 2002 41 49
24. J.D. Flax, S. Aurora, C. Yang, C. Simonin, A.M. Wills, and L.L. Billinghurst Engraftable human neural stem cells respond to developmental cues, replace neurons, and express foreign genes Nat Biotechnol 16 1998 1033 1039
25. R. McKay Stem cells in the central nervous system Science 276 1997 66 71
26. N. Uchida, D.W. Buck, D. He, M.J. Reitsma, M. Masek, and T.V. Phan Direct isolation of human central nervous system stem cells Proc Natl Acad Sci U S A 97 2000 14720 14725
27. D.J. Mathews, J. Sugarman, H. Bok, D.M. Blass, J.T. Coyle, and P. Duggan Cell-based interventions for neurologic conditions: ethical challenges for early human trials Neurology 71 2008 288 293
28. P. Bossolasco, L. Cova, C. Calzarossa, S.G. Rimoldi, C. Borsotti, and G.L. Deliliers Neuro-glial differentiation of human bone marrow stem cells in vitro Exp Neurol 193 2005 312 325
29. M.F. Pittenger, A.M. Mackay, S.C. Beck, R.K. Jaiswal, R. Douglas, and J.D. Mosca Multilineage potential of adult human mesenchymal stem cells Science 284 1999 143 147
30. J. Sanchez-Ramos, S. Song, F. Cardozo-Pelaez, C. Hazzi, T. Stedeford, and A. Willing Adult bone marrow stromal cells differentiate into neural cells in vitro Exp Neurol 164 2000 247 256
31. K.W. Liechty, T.C. MacKenzie, A.F. Shaaban, A. Radu, A.M. Moseley, and R. Deans Human mesenchymal stem cells engraft and demonstrate site-specific differentiation after in utero transplantation in sheep Nat Med 6 2000 1282 1286
32. A. Uccelli, L. Moretta, and V. Pistoia Mesenchymal stem cells in health and disease Nat Rev Immunol 8 2008 726 736
33. A.I. Caplan, and J.E. Dennis Mesenchymal stem cells as trophic mediators J Cell Biochem 98 2006 1076 1084
34. D. Karussis, C. Karageorgiou, A. Vaknin-Dembinsky, B. Gowda-Kurkalli, J.M. Gomori, and I. Kassis Safety and immunological effects of mesenchymal stem cell transplantation in patients with multiple sclerosis and amyotrophic lateral sclerosis Arch Neurol 67 2010 1187 1194
35. B. Yamout, R. Hourani, H. Salti, W. Barada, T. El-Hajj, and A. Al-Kutoubi Bone marrow mesenchymal stem cell transplantation in patients with multiple sclerosis: a pilot study J Neuroimmunol 227 2010 185 189
36. L. Mazzini, K. Mareschi, I. Ferrero, M. Miglioretti, A. Stecco, and S. Servo Mesenchymal stromal cell transplantation in amyotrophic lateral sclerosis: a long-term safety study Cytotherapy 14 2012 56 60
37. L. Mazzini, I. Ferrero, V. Luparello, D. Rustichelli, M. Gunetti, and K. Mareschi Mesenchymal stem cell transplantation in amyotrophic lateral sclerosis: a phase I clinical trial Exp Neurol 223 2010 229 237
38. M. Nakagawa, M. Koyanagi, K. Tanabe, K. Takahashi, T. Ichisaka, and T. Aoi Generation of induced pluripotent stem cells without Myc from mouse and human fibroblasts Nat Biotechnol 26 2008 101 106
39. K. Okita, T. Ichisaka, and S. Yamanaka Generation of germline-competent induced pluripotent stem cells Nature 448 2007 313 317
40. K. Takahashi, K. Tanabe, M. Ohnuki, M. Narita, T. Ichisaka, and K. Tomoda Induction of pluripotent stem cells from adult human fibroblasts by defined factors Cell 131 2007 861 872
41. K. Takahashi, and S. Yamanaka Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors Cell 126 2006 663 676
42. J. Yu, M.A. Vodyanik, K. Smuga-Otto, J. Antosiewicz-Bourget, J.L. Frane, and S. Tian Induced pluripotent stem cell lines derived from human somatic cells Science 318 2007 1917 1920
43. O. Einstein, D. Karussis, N. Grigoriadis, R. Mizrachi-Kol, E. Reinhartz, and O. Abramsky Intraventricular transplantation of neural precursor cell spheres attenuates acute experimental allergic encephalomyelitis Mol Cell Neurosci 24 2003 1074 1082
44. C.P. Genain, T. Roberts, R.L. Davis, M.H. Nguyen, A. Uccelli, and D. Faulds Prevention of autoimmune demyelination in non-human primates by a cAMP-specific phosphodiesterase inhibitor Proc Natl Acad Sci U S A 92 1995 3601 3605
45. O. Isacson, T.W. Deacon, P. Pakzaban, W.R. Galpern, J. Dinsmore, and L.H. Burns Transplanted xenogeneic neural cells in neurodegenerative disease models exhibit remarkable axonal target specificity and distinct growth patterns of glial and axonal fibres Nat Med 1 1995 1189 1194
46. D.M. Karussis, S. Slavin, D. Lehmann, R. Mizrachi-Koll, O. Abramsky, and A. Ben-Nun Prevention of experimental autoimmune encephalomyelitis and induction of tolerance with acute immunosuppression followed by syngeneic bone marrow transplantation J Immunol 148 1992 1693 1698
47. A.J. Nauta, and W.E. Fibbe Immunomodulatory properties of mesenchymal stromal cells Blood 110 2007 3499 3506
48. O.N. Koc, J. Day, M. Nieder, S.L. Gerson, H.M. Lazarus, and W. Krivit Allogeneic mesenchymal stem cell infusion for treatment of metachromatic leukodystrophy (MLD) and Hurler syndrome (MPS-IH) Bone Marrow Transplant 30 2002 215 222
49. N. Eliopoulos, J. Stagg, L. Lejeune, S. Pommey, and J. Galipeau Allogeneic marrow stromal cells are immune rejected by MHC class I- and class II-mismatched recipient mice Blood 106 2005 4057 4065
50. S. Pluchino, A. Gritti, E. Blezer, S. Amadio, E. Brambilla, and G. Borsellino Human neural stem cells ameliorate autoimmune encephalomyelitis in non-human primates Ann Neurol 66 2009 343 354
51. A. Uccelli, and D.J. Prockop Why should mesenchymal stem cells (MSCs) cure autoimmune diseases? Curr Opin Immunol 22 2010 768 774
52. F. Fandrich, B. Dresske, M. Bader, and M. Schulze Embryonic stem cells share immune-privileged features relevant for tolerance induction J Mol Med 80 2002 343 350
53. L. Li, M.L. Baroja, A. Majumdar, K. Chadwick, A. Rouleau, and L. Gallacher Human embryonic stem cells possess immune-privileged properties Stem Cells 22 2004 448 456
54. D. Kondziolka, L. Wechsler, S. Goldstein, C. Meltzer, K.R. Thulborn, and J. Gebel Transplantation of cultured human neuronal cells for patients with stroke Neurology 55 2000 565 569
55. D. Kondziolka, G.K. Steinberg, L. Wechsler, C.C. Meltzer, E. Elder, and J. Gebel Neurotransplantation for patients with subcortical motor stroke: a phase 2 randomized trial J Neurosurg 103 2005 38 45
56. S.I. Savitz, J. Dinsmore, J. Wu, G.V. Henderson, P. Stieg, and L.R. Caplan Neurotransplantation of fetal porcine cells in patients with basal ganglia infarcts: a preliminary safety and feasibility study Cerebrovasc Dis 20 2005 101 107
57. J.S. Lee, J.M. Hong, G.J. Moon, P.H. Lee, Y.H. Ahn, and O.Y. Bang A long-term follow-up study of intravenous autologous mesenchymal stem cell transplantation in patients with ischemic stroke Stem Cells 28 2010 1099 1106
58. O.Y. Bang, J.S. Lee, P.H. Lee, and G. Lee Autologous mesenchymal stem cell transplantation in stroke patients Ann Neurol 57 2005 874 882
59. R.H. Andres, R. Choi, G.K. Steinberg, and R. Guzman Potential of adult neural stem cells in stroke therapy Regen Med 3 2008 893 905
60. T.M. Bliss, R.H. Andres, and G.K. Steinberg Optimizing the success of cell transplantation therapy for stroke Neurobiol Dis 37 2010 275 283
61. O. Lindvall Stem cells for cell therapy in Parkinson's disease Pharmacol Res 47 2003 279 287
62. O. Sadan, M. Bahat-Stromza, Y. Barhum, Y.S. Levy, A. Pisnevsky, and H. Peretz Protective effects of neurotrophic factor-secreting cells in a 6-OHDA rat model of Parkinson disease Stem Cells Dev 18 2009 1179 1190
63. J.H. Kim, J.M. Auerbach, J.A. Rodriguez-Gomez, I. Velasco, D. Gavin, and N. Lumelsky Dopamine neurons derived from embryonic stem cells function in an animal model of Parkinson's disease Nature 418 2002 50 56
64. O. Lindvall, and Z. Kokaia Prospects of stem cell therapy for replacing dopamine neurons in Parkinson's disease Trends Pharmacol Sci 30 2009 260 267
65. O. Lindvall, Z. Kokaia, and A. Martinez-Serrano Stem cell therapy for human neurodegenerative disorders - how to make it work Nat Med Suppl. 10 2004 S42 S50
66. I. Mendez, A. Dagher, M. Hong, P. Gaudet, S. Weerasinghe, and V. McAlister Simultaneous intrastriatal and intranigral fetal dopaminergic grafts in patients with Parkinson disease: a pilot study. Report of three cases J Neurosurg 96 2002 589 596
67. R.E. Gross, R.L. Watts, R.A. Hauser, R.A. Bakay, H. Reichmann, and R. von Kummer Intrastriatal transplantation of microcarrier-bound human retinal pigment epithelial cells versus sham surgery in patients with advanced Parkinson's disease: a double-blind, randomised, controlled trial Lancet Neurol 10 2011 509 519
68. C.R. Freed, P.E. Greene, R.E. Breeze, W.Y. Tsai, W. DuMouchel, and R. Kao Transplantation of embryonic dopamine neurons for severe Parkinson's disease N Engl J Med 344 2001 710 719
69. C.W. Olanow, C.G. Goetz, J.H. Kordower, A.J. Stoessl, V. Sossi, and M.F. Brin A double-blind controlled trial of bilateral fetal nigral transplantation in Parkinson's disease Ann Neurol 54 2003 403 414
70. S.B. Dunnett, and A.E. Rosser Stem cell transplantation for Huntington's disease Exp Neurol 203 2007 279 292
71. A. Bachoud-Levi, C. Bourdet, P. Brugieres, J.P. Nguyen, T. Grandmougin, and B. Haddad Safety and tolerability assessment of intrastriatal neural allografts in five patients with Huntington's disease Exp Neurol 161 2000 194 202
72. A.C. Bachoud-Levi, V. Gaura, P. Brugieres, J.P. Lefaucheur, M.F. Boisse, and P. Maison Effect of fetal neural transplants in patients with Huntington's disease 6 years after surgery: a long-term follow-up study Lancet Neurol 5 2006 303 309
73. P. Krystkowiak, V. Gaura, M. Labalette, A. Rialland, P. Remy, and M. Peschanski Alloimmunisation to donor antigens and immune rejection following foetal neural grafts to the brain in patients with Huntington's disease PLoS One 2 2007 e166
74. C.D. Keene, R.C. Chang, J.B. Leverenz, O. Kopyov, S. Perlman, and R.F. Hevner A patient with Huntington's disease and long-surviving fetal neural transplants that developed mass lesions Acta Neuropathol 117 2009 329 338
75. P. Capetian, R. Knoth, J. Maciaczyk, G. Pantazis, M. Ditter, and L. Bokla Histological findings on fetal striatal grafts in a Huntington's disease patient early after transplantation Neuroscience 160 2009 661 675
76. I. Reuter, Y.F. Tai, N. Pavese, K.R. Chaudhuri, S. Mason, and C.E. Polkey Long-term clinical and positron emission tomography outcome of fetal striatal transplantation in Huntington's disease J Neurol Neurosurg Psychiatry 79 2008 948 951
77. F. Cicchetti, S. Saporta, R.A. Hauser, M. Parent, M. Saint-Pierre, and P.R. Sanberg Neural transplants in patients with Huntington's disease undergo disease-like neuronal degeneration Proc Natl Acad Sci U S A 106 2009 12483 12488
78. P.H. Lee, J.E. Lee, H.S. Kim, S.K. Song, H.S. Lee, and H.S. Nam A randomized trial of mesenchymal stem cells in multiple system atrophy Ann Neurol 72 2012 32 40
79. S. Forostyak, P. Jendelova, M. Kapcalova, D. Arboleda, and E. Sykova Mesenchymal stromal cells prolong the lifespan in a rat model of amyotrophic lateral sclerosis Cytotherapy 13 2011 1036 1046
80. A. Vercelli, O.M. Mereuta, D. Garbossa, G. Muraca, K. Mareschi, and D. Rustichelli Human mesenchymal stem cell transplantation extends survival, improves motor performance and decreases neuroinflammation in mouse model of amyotrophic lateral sclerosis Neurobiol Dis 31 2008 395 405
81. Uccelli A, Milanese M, Principato MC, Morando S, Bonifacino T, Vergani L, et al. 757 Intravenous mesenchymal stem cells improve survival and motor function in ex- 758 perimental amyotrophic lateral sclerosis, Mol Med 2012;18(1):794-80.
82. H. Deda, M.C. Inci, A.E. Kurekci, A. Sav, K. Kayihan, and E. Ozgun Treatment of amyotrophic lateral sclerosis patients by autologous bone marrow-derived hematopoietic stem cell transplantation: a 1-year follow-up Cytotherapy 11 2009 18 25
83. R. Traub, H. Mitsumoto, and L.P. Rowland Research advances in amyotrophic lateral sclerosis, 2009 to 2010 Curr Neurol Neurosci Rep 11 2011 67 77
84. D.R. Beers, J.S. Henkel, Q. Xiao, W. Zhao, J. Wang, and A.A. Yen Wild-type microglia extend survival in PU.1 knockout mice with familial amyotrophic lateral sclerosis Proc Natl Acad Sci U S A 103 2006 16021 16026
85. S.H. Appel, J.I. Engelhardt, J.S. Henkel, L. Siklos, D.R. Beers, and A.A. Yen Hematopoietic stem cell transplantation in patients with sporadic amyotrophic lateral sclerosis Neurology 71 2008 1326 1334
86. S. Corti, F. Locatelli, D. Papadimitriou, R. Del Bo, M. Nizzardo, and M. Nardini Neural stem cells LewisX + CXCR4 + modify disease progression in an amyotrophic lateral sclerosis model Brain 130 2007 1289 1305
87. L. Xu, J. Yan, D. Chen, A.M. Welsh, T. Hazel, and K. Johe Human neural stem cell grafts ameliorate motor neuron disease in SOD-1 transgenic rats Transplantation 82 2006 865 875
88. J.T. Dimos, K.T. Rodolfa, K.K. Niakan, L.M. Weisenthal, H. Mitsumoto, and W. Chung Induced pluripotent stem cells generated from patients with ALS can be differentiated into motor neurons Science 321 2008 1218 1221
89. S. Karumbayaram, B.G. Novitch, M. Patterson, J.A. Umbach, L. Richter, and A. Lindgren Directed differentiation of human-induced pluripotent stem cells generates active motor neurons Stem Cells 27 2009 806 811
90. T. Ben-Hur, O. Einstein, R. Mizrachi-Kol, O. Ben-Menachem, E. Reinhartz, and D. Karussis Transplanted multipotential neural precursor cells migrate into the inflamed white matter in response to experimental autoimmune encephalomyelitis Glia 41 2003 73 80
91. M. Aharonowiz, O. Einstein, N. Fainstein, H. Lassmann, B. Reubinoff, and T. Ben-Hur Neuroprotective effect of transplanted human embryonic stem cell-derived neural precursors in an animal model of multiple sclerosis PLoS One 3 2008 e3145
92. E. Gerdoni, B. Gallo, S. Casazza, S. Musio, I. Bonanni, and E. Pedemonte Mesenchymal stem cells effectively modulate pathogenic immune response in experimental autoimmune encephalomyelitis Ann Neurol 61 2007 219 227
93. M.S. Freedman, A. Bar-Or, H.L. Atkins, D. Karussis, F. Frassoni, and H. Lazarus The therapeutic potential of mesenchymal stem cell transplantation as a treatment for multiple sclerosis: consensus report of the International MSCT Study Group Mult Scler 16 2010 503 510
94. A. Uccelli, A. Laroni, and M.S. Freedman Mesenchymal stem cells for the treatment of multiple sclerosis and other neurological diseases Lancet Neurol 10 2011 649 656
95. P. Connick, M. Kolappan, C. Crawley, D.J. Webber, R. Patani, and A.W. Michell Autologous mesenchymal stem cells for the treatment of secondary progressive multiple sclerosis: an open-label phase 2a proof-of-concept study Lancet Neurol 11 2012 150 156
96. P.A. Muraro, D.C. Douek, A. Packer, K. Chung, F.J. Guenaga, and R. Cassiani-Ingoni Thymic output generates a new and diverse TCR repertoire after autologous stem cell transplantation in multiple sclerosis patients J Exp Med 201 2005 805 816
97. R.K. Burt, B.A. Cohen, E. Russell, K. Spero, A. Joshi, and Y. Oyama Hematopoietic stem cell transplantation for progressive multiple sclerosis: failure of a total body irradiation-based conditioning regimen to prevent disease progression in patients with high disability scores Blood 102 2003 2373 2378
98. D. Karussis, and A. Vaknin-Dembinsky Hematopoietic stem cell transplantation in multiple sclerosis: a review of the clinical experience and a report of an international meeting Expert Rev Clin Immunol 6 2010 347 352
99. A. Fassas, A. Anagnostopoulos, A. Kazis, K. Kapinas, I. Sakellari, and V. Kimiskidis Peripheral blood stem cell transplantation in the treatment of progressive multiple sclerosis: first results of a pilot study Bone Marrow Transplant 20 1997 631 638
100. R.K. Burt, Y. Loh, B. Cohen, D. Stefoski, R. Balabanov, and G. Katsamakis Autologous non-myeloablative haemopoietic stem cell transplantation in relapsing-remitting multiple sclerosis: a phase I/II study Lancet Neurol 8 2009 244 253
101. R. Saccardi, G.L. Mancardi, A. Solari, A. Bosi, P. Bruzzi, and P. Di Bartolomeo Autologous HSCT for severe progressive multiple sclerosis in a multicenter trial: impact on disease activity and quality of life Blood 105 2005 2601 2607
102. X.S. Ni, J. Ouyang, W.H. Zhu, C. Wang, and B. Chen Autologous hematopoietic stem cell transplantation for progressive multiple sclerosis: report of efficacy and safety at three yr of follow up in 21 patients Clin Transplant 20 2006 485 489
103. E. Krasulova, M. Trneny, T. Kozak, B. Vackova, D. Pohlreich, and D. Kemlink High-dose immunoablation with autologous haematopoietic stem cell transplantation in aggressive multiple sclerosis: a single centre 10-year experience Mult Scler 16 2010 685 693
104. G.L. Mancardi, M.P. Sormani, M. Di Gioia, L. Vuolo, F. Gualandi, and M.P. Amato Autologous haematopoietic stem cell transplantation with an intermediate intensity conditioning regimen in multiple sclerosis: the Italian multi-centre experience Mult Scler 18 2012 835 842
105. R.E. Field, J.A. Buchanan, M.G. Copplemans, and P.M. Aichroth Bone-marrow transplantation in Hurler's syndrome. Effect on skeletal development J Bone Joint Surg Br 76 1994 975 981
106. W. Krivit, C. Peters, and E.G. Shapiro Bone marrow transplantation as effective treatment of central nervous system disease in globoid cell leukodystrophy, metachromatic leukodystrophy, adrenoleukodystrophy, mannosidosis, fucosidosis, aspartylglucosaminuria, Hurler, Maroteaux-Lamy, and Sly syndromes, and Gaucher disease type III Curr Opin Neurol 12 1999 167 176
107. H.K. Jin, J.E. Carter, G.W. Huntley, and E.H. Schuchman Intracerebral transplantation of mesenchymal stem cells into acid sphingomyelinase-deficient mice delays the onset of neurological abnormalities and extends their life span J Clin Invest 109 2002 1183 1191
108. T. Barberi, M. Bradbury, Z. Dincer, G. Panagiotakos, N.D. Socci, and L. Studer Derivation of engraftable skeletal myoblasts from human embryonic stem cells Nat Med 13 2007 642 648
109. R. Darabi, K. Gehlbach, R.M. Bachoo, S. Kamath, M. Osawa, and K.E. Kamm Functional skeletal muscle regeneration from differentiating embryonic stem cells Nat Med 14 2008 134 143
110. C. De Bari, F. Dell'Accio, F. Vandenabeele, J.R. Vermeesch, J.M. Raymackers, and F.P. Luyten Skeletal muscle repair by adult human mesenchymal stem cells from synovial membrane J Cell Biol 160 2003 909 918
111. E. Gussoni, R.R. Bennett, K.R. Muskiewicz, T. Meyerrose, J.A. Nolta, and I. Gilgoff Long-term persistence of donor nuclei in a Duchenne muscular dystrophy patient receiving bone marrow transplantation J Clin Invest 110 2002 807 814
112. K.A. Lapidos, Y.E. Chen, J.U. Earley, A. Heydemann, J.M. Huber, and M. Chien Transplanted hematopoietic stem cells demonstrate impaired sarcoglycan expression after engraftment into cardiac and skeletal muscle J Clin Invest 114 2004 1577 1585
113. G. Wernig, V. Janzen, R. Schafer, M. Zweyer, U. Knauf, and O. Hoegemeier The vast majority of bone-marrow-derived cells integrated into mdx muscle fibers are silent despite long-term engraftment Proc Natl Acad Sci U S A 102 2005 11852 11857
114. C. Dell'Agnola, Z. Wang, R. Storb, S.J. Tapscott, C.S. Kuhr, and S.D. Hauschka Hematopoietic stem cell transplantation does not restore dystrophin expression in Duchenne muscular dystrophy dogs Blood 104 2004 4311 4318
115. M. Sampaolesi, Y. Torrente, A. Innocenzi, R. Tonlorenzi, G. D'Antona, and M.A. Pellegrino Cell therapy of alpha-sarcoglycan null dystrophic mice through intra-arterial delivery of mesoangioblasts Science 301 2003 487 492
116. M. Sampaolesi, S. Blot, G. D'Antona, N. Granger, R. Tonlorenzi, and A. Innocenzi Mesoangioblast stem cells ameliorate muscle function in dystrophic dogs Nature 444 2006 574 579
117. R. Benchaouir, M. Meregalli, A. Farini, G. D'Antona, M. Belicchi, and A. Goyenvalle Restoration of human dystrophin following transplantation of exon-skipping-engineered DMD patient stem cells into dystrophic mice Cell Stem Cell 1 2007 646 657
118. Y. Torrente, M. Belicchi, C. Marchesi, G. Dantona, F. Cogiamanian, and F. Pisati Autologous transplantation of muscle-derived CD133 + stem cells in Duchenne muscle patients Cell Transplant 16 2007 563 577
119. A Yazan, Coons Stephen, and K. Chapman Catastrophic demyelinating encephalomyelitis after intrathecal and intravenous stem cell transplantation in a patient with multiple sclerosis. J Child Neurol 27 5 2012 632 635 [Epub 2011 Dec 7]
120. N. Amariglio, A. Hirshberg, B.W. Scheithauer, Y. Cohen, R. Loewenthal, and L. Trakhtenbrot Donor-derived brain tumor following neural stem cell transplantation in an ataxia telangiectasia patient PLoS Med 6 2009 e1000029
121. RE Field, JA Buchanan, MG Copplemans, and PM Aichroth Bone-marrow transplantation in Hurler's syndrome. Effect on skeletal development J Bone Joint Surg Br 76 1994 975 981